K. Ewe
- Gastroenterology top 5%
- Gastrointestinal motility and disorders 7
- Genetics top 5%
- Inflammatory Bowel Disease 12
- Surgery top 10%
- Pediatric Hepatobiliary Diseases and Treatments 4
- Esophageal and GI Pathology 3
- Eosinophilic Esophagitis 2
- Epidemiology top 10%
- Microscopic Colitis 8
- Autoimmune and Inflammatory Disorders 4
-
- Gallbladder and Bile Duct Disorders 5
- Co-authors
- K. H. Meyer zum BüschenfeldeM. StaritzH MalchowH. J. JesdinskyC HerfarthH SommerS. JarnumH Leonhardt
- Cited by
- GastroenterologyGeneticsSurgery
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
K. Ewe
30 papers receiving 827 citations
Peers
Comparison fields: 5 of 66
- Gastroenterology 122
- Genetics 411
- Surgery 517
- Epidemiology 358
- Pulmonary and Respiratory Medicine 280
Countries citing papers authored by K. Ewe
This map shows the geographic impact of K. Ewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Ewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Ewe more than expected).
Fields of papers citing papers by K. Ewe
This network shows the impact of papers produced by K. Ewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Ewe. The network helps show where K. Ewe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside K. Ewe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 11 | |
| 2 | 2008 | 2 | |
| 3 | Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group. | 1997 | 18 |
| 4 | Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group. | 1996 | 83 |
| 5 | Treatment of active Crohn's ileocolitis with oral pH-modified budesonide. Germany Budesonide Study Group. | 1995 | 11 |
| 6 | 1993 | 12 | |
| 7 | 1992 | 18 | |
| 8 | 1991 | 10 | |
| 9 | 1990 | 93 | |
| 10 | [The treatment of irritable colon. Efficacy and tolerance of buscopan plus, buscopan, paracetamol and placebo in ambulatory patients with irritable colon]. | 1990 | 37 |
| 11 | 1989 | 111 | |
| 12 | 1988 | 26 | |
| 13 | 1986 | 2 | |
| 14 | 1985 | 75 | |
| 15 | [Amebic colitis - differential diagnosis of ulcerative colitis and Crohn disease]. | 1984 | 2 |
| 16 | 1983 | 18 | |
| 17 | 1983 | 163 | |
| 18 | [(Quality of semen in patients with Crohn's disease) ]. | 1982 | 11 |
| 19 | [Surgical and internal medicine therapy study of the postoperative prevention of recurrence in Crohn's disease - completion of a partly randomized study]. | 1980 | 3 |
| 20 | 1974 | 5 |
About K. Ewe
K. Ewe is a scholar working on Gastroenterology, Genetics and Surgery, having authored 30 papers that have together received 867 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (12 papers), Microscopic Colitis (8 papers), Gastrointestinal motility and disorders (7 papers), Gallbladder and Bile Duct Disorders (5 papers), Pediatric Hepatobiliary Diseases and Treatments (4 papers), Autoimmune and Inflammatory Disorders (4 papers), Esophageal and GI Pathology (3 papers) and Eosinophilic Esophagitis (2 papers). The work is most often cited by research in Gastroenterology (122 citations), Genetics (411 citations) and Surgery (517 citations). K. Ewe has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include K. H. Meyer zum Büschenfelde, M. Staritz, H Malchow, H. J. Jesdinsky, C Herfarth, H Sommer, S. Jarnum, H Leonhardt, H. Lorenz‐Meyer and W. D. Strohm. Their work appears in journals such as Digestion, Endoscopy, Pharmacology, Gut and Diseases of the Colon & Rectum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.